Overview

Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty

Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the analgesic efficacy of Dexmedetomidine Transdermal System (DMTS), compared with placebo, in participants following abdominoplasty.
Phase:
Phase 2
Details
Lead Sponsor:
Teikoku Pharma USA, Inc.
Treatments:
Dexmedetomidine